Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

binetrakin

A recombinant agent chemically identical to or similar to the endogenous cytokine interleukin-4 (IL-4). Produced primarily by activated T cells, IL-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B cells and enhancing their ability to present antigens to T cells. As a potential immunotherapeutic agent, binetrakin also augments the effects of other cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:B-cell growth factor
B-cell proliferating factor
B-cell stimulating factor
B-cell stimulatory factor 1
interleukin 4 (human) 129
interleukin-4
mast cell growth factor-2
recombinant human IL-4
T-cell growth factor 2
Abbreviation:BCGF
BCSF 1
IL-4
MCGF 2
RHIL-4
Code name:SCH 93400
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search